Tesamorelin's pivotal data comes from two phase-3 trials in roughly 800 participants with HIV-associated lipodystrophy
According to Truveta Research presented at ISPOR 2025, side effects were the leading reason patients stopped taking GLP-1 medications, accounting for 28.2% of all discontinuations
Zhou HY, Feng X, Wang LW et al (2023) Bone marrow immune cells respond to fluctuating nutritional stress to constrain weight regain
7 Untreated, MASH can lead to fibrosis, cirrhosis, and, potentially, hepatocellular carcinoma
Gender difference in glutathione metabolism during aging in mice
So its really worth looking into